ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Drops Two CCOPS, Cincinnati And West Virginia, For Lack Of Patient Entry; 60 Funded Another Year

August 24, 1984

MSKCC oncologist settles insider trading case with SEC.

November 11, 2005

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

OMB Reprogramming Ban Criticized

September 20, 1985

In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill

July 6, 1979

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011